Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Climate and the Environment - impact on Global and Mental Health

The climate crisis is a health emergency which is threatening the lives and wellbeing of communities around the world in many ways – including through air pollution, rising temperatures, the spread of infectious diseases and antimicrobial resistance.

Expert Comment: Is an interdisciplinary research approach key to tackling global challenges?

Professor Christine Gerrard, Director of The Oxford Research Centre in the Humanities (TORCH) and Professor of eighteenth-century literature and culture, explores interdisciplinary research as a 'magic bullet' to tackle major global challenges such as the climate crisis, democratic stability and global health inequity.

Nearly 500,000 children could die from AIDS-related causes by 2030 without stable PEPFAR programmes, Oxford experts estimate

Oxford experts estimate that 1 million additional children could become infected with HIV and nearly 500,000 children could die from AIDS by 2030, while as many as 2.8 million children could become orphaned in the next five years if US President’s Emergency Plan for AIDS Relief (PEPFAR) programmes are reduced or eliminated.

Addressing healthcare workforce challenges with new research partnership

Researchers from the Nuffield Department of Primary Care Health Sciences are part of a major new research initiative aimed at tackling critical workforce challenges in healthcare, particularly in underserved communities.

Celebrate World Health Worker Week

The world is facing a shortage of 11 million health workers by 2030. World Health Worker Week calls for increased investment in all cadres of the health workforce - nurses, doctors, pharmacists, and others vital to resilient health systems. Health workers save lives, support economies, and advance development goals. Collaborative efforts, such as OUCRU’s training programme in Dak Lak, Vietnam, demonstrate the benefits of investment, with increased vaccine uptake. Protecting, valuing, and training health workers strengthens global health.

KEMRI signs landmark partnership with Wellcome and Oxford

The Kenya Medical Research Institute (KEMRI) has officially entered into a seven-year Memorandum of Understanding (MoU) with Wellcome, a UK-based charitable foundation, and the University of Oxford. The £91 million agreement was signed at the Wellcome headquarters in London, marking a significant boost for medical research and training in Kenya.

New Co-Associate Directors of Oxford Global Health

We are pleased to announce the appointment of Professor Susanna Dunachie and Dr Caesar Atuire as Co-Associate Directors of Oxford Global Health.

New science partnership to strengthen Africa’s pandemic resilience

A groundbreaking research partnership is set to enhance Africa’s preparedness and response to future health crises.

First human trial of aerosol vaccine delivery launched

The Jenner Institute, in partnership with the Coler Lab at Seattle Children’s Research Institute (SCRI), is set to begin a new clinical trial to test tuberculosis (TB) vaccine safety and the host immune response in a first-in-man aerosol mycobacterial challenge infection model with healthy adult volunteers.

Prioritising research to better address high-consequence outbreaks

A new paper published in BMC Medicine analyses research prioritisation approaches for high-consequence pathogens.

Africa’s change-makers: meet the Mastercard Foundation Scholars with big ambitions for the future

By 2050, Africa will host a majority of the world's student-age population, shaping global futures. The Mastercard Foundation Scholars at Oxford's Africa Oxford Initiative receive full scholarships, rigorous education, leadership training, entrepreneurship support and networking, preparing them to lead Africa's and the world's future challenges and opportunities.

60% of hepatitis C patients do not know how they had the disease

A survey at Vietnam's National Hospital for Tropical Diseases found 60% of hepatitis C patients unaware of how they contracted the disease, often diagnosed late. Globally, viral hepatitis causes 3,500 daily deaths, ranking second among infectious killers after tuberculosis.

Study finds previously unidentified genetic determinants of rare disease

A landmark study involving researchers from NDM’s Centre for Human Genetics has identified 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.

Spotlight on Magdalen College Chapel for Rare Disease Day

The chapel facade of Magdalen College was lit up ahead of the commemoration of Rare Disease Day (RDD) which was celebrated on Friday 28th February 2025. The celebration is held on 29th February in a leap year as it is the rarest day in the year.

Study provides support for WHO guidelines for treating pregnant women with HIV

A new analysis by researchers at Oxford Population Health’s Infectious Disease Epidemiology Unit has provided robust evidence in support of current World Health Organization (WHO) guidelines for treating pregnant women living with HIV. The study is published in Clinical Microbiology and Infection.

IOI awards £5m to Oxford consortium to develop new therapies for drug-resistant tuberculosis

The Ineos Oxford Institute for antimicrobial research (IOI) has awarded £5 million to a group of 17 interdisciplinary researchers from Oxford University to develop new therapies for drug-resistant tuberculosis.

Bangladesh malaria mass vaccine and drug administration trial begins

After more than a year of community engagement and preparation in 100 villages with 12,000 populations across the Chittagong Hill Tracts, the mass malaria vaccine (R21/Matrix M) and drug (DHA, piperaquine, and single low dose primaquine) administration study started on 15 Feb.

Advances in AI can help prepare the world for the next pandemic

In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.

Researchers develop AI-powered tools to improve pneumonia care

A team of researchers at OUCRU was recently awarded a multi-million-dollar Discovery Award from the Wellcome Trust to develop AI tools to advance pneumonia research.

British and Japanese young people make mental health recommendations for public health emergencies

Twenty eight young people from the UK and Japan played a leading role in co-designing the research, interviewing other young people and adults, analysing the findings, and developing the recommendations for policy makers.

Load More